PBS listing for first pan-genotypic antiviral hep C treatment

liver with hepatitis virus render
Hepatitis Australia has welcomed today’s announcement that a new hepatitis C drug will be listed on the PBS Epclusa, the first pan-genotypic antiviral, will be PBS listed from 1 August, Health Minister Greg Hunt said today, World Hepatitis Day (July 28). Epclusa (sofosbuvir 400 mg/velpatasvir 100 mg) is a pan-genotypic regimen for the treatment of

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous National real-time monitoring system announced
Next The stars of pharmacy